The effects of ^-blocking and class I antiarrhythmic agents on free radical-mediated sarcolemmal lipid peroxidation were examined. Highly purified canine myocytic sarcolemmal membranes were pretreated with 10-800 /iM of selected ^-blocking (propranolol, pindolol, metoprolol, atenolol, or sotalol) and class I (quinidine, lidocaine, procainamide, or diphenylhydantoin) antiarrhythmic agents at 37° C for 10 minutes. Subsequently, a superoxide radical (derived from dihydroxyfumarate) driven, Fe The phospholipid-rich sarcolemma of ventricular myocytes may be a major site of free radical attack. We recently reported that isolated canine myocytic sarcolemmal membranes were readily peroxidized by free oxygen radicals 5 ; in addition, the reactions were greatly influenced by the presence of lipid amphiphiles. 6 Most clinically used antiarrhythmic agents are amphiphilic in nature 7 and may readily partition into the hydrophobic regions of the sarcolemmal membrane; we sought to determine whether the sensitivity of the membrane to free radical attack might be affected. In the present study, we selected several /3-blockers and class I antiarrhythmic agents Supported by a Grant-in-Aid from the American Heart Association, Nation's Capitol Affiliate, and by National Institutes of Health grants R0I-HL364I8 and P0I-HL380790.
D
uring cardiac ischemia, free oxygen radicals have been reported to increase upon reperfusion.'- 4 The phospholipid-rich sarcolemma of ventricular myocytes may be a major site of free radical attack. We recently reported that isolated canine myocytic sarcolemmal membranes were readily peroxidized by free oxygen radicals 5 ; in addition, the reactions were greatly influenced by the presence of lipid amphiphiles. 6 Most clinically used antiarrhythmic agents are amphiphilic in nature 7 and may readily partition into the hydrophobic regions of the sarcolemmal membrane; we sought to determine whether the sensitivity of the membrane to free radical attack might be affected. In the present study, we selected several /3-blockers and class I antiarrhythmic agents and examined their dose-related effects on free radical-mediated peroxidation in highly purified sarcolemmal membranes.
Materials and Methods

Materials
Dihydroxyfumarate (DHF), ADP, FeCl 3 • 6H 2 O, 2-thiobarbituric acid, DL-propranolol, pindolol, metoprolol-tartrate, atenolol, sotalol, quinidine, lidocaine, procainamide-HCI, and 5,5-diphenylhydantoin were purchased from Sigma Chemical, St. Louis, Missouri; naphthalene and 1-methoxynaphthalene were from Fisher Scientific. Sarcolemmal membranes were prepared from adult canine myocytes according to the procedure of Weglicki et al. 8 Briefly, the myocytes were isolated from ventricular tissues by digestion with 0.2% collagenase. Freshly isolated myocytes were then disrupted by nitrogen cavitation (500 PSI 30 minutes, 4° C), and the sarcolemmal membranes were enriched by differential and sucrose density centrifugations. The sarcolemmal fractions used for these studies were enriched at least 50-fold in the specific activities of the marker enzymes K + -dependent p-nitrophenyl phosphatase and Na,K-ATPase.
Incubation Procedure and Measurement of Lipid Peroxidation
For this study, free radicals were generated from our established superoxide anion-driven, ironcatalyzed free radical system. 5 -6 -9 Superoxide anions were generated during the auto-oxidation of DHF; iron was present as Fe 3+ -ADP chelate. Sarcolemmal membranes (75-100 fig protein/ml) were preincubated with or without each antiarrhythmic agent at specified concentrations for 10 minutes at 37° C in a reaction buffer consisting of 120 mM KCI, 50 mM sucrose, and 10 mM potassium phosphate, pH 7.2 or 6.0. Other conditions are described in "Results." Reactions were initiated by the final additions of freshly prepared Fe 3+ -ADP (0.025 mM FeCl 3 chelated by 0.25 mM ADP) and 0.83 mM DHF. The rates of membrane lipid peroxidation were measured by the formation of malondialdehyde (MDA), which was determined by the thiobarbituric acid (TBA) method as described previously. 9 To prevent nonspecific color formation due to overheating, 10 the temperature of the chromophore development step was maintained at 80° C (for 30 minutes). Under these conditions, complete development of the TBA-MDA value was achieved, and no interference from the sucrose and iron in the Time at 37°C (ntin) Results With the chosen levels of the free radical generating components, the time course of lipid peroxidation in the control samples is presented in Figure  1 . At 20 minutes, the level of MDA formed in the control samples was 39.9±3.8 nmol/mg protein.
The effects of the five /3-blocking and four class I antiarrhythmic agents on the induced sarcolemmal lipid peroxidation are summarized in Table 1 . The four class I antiarrhythmic agents only showed modest (<20%) effects. However, pretreatment of the sarcolemmal membranes for at least 10 minutes with the ^-blocking agents resulted in significant (p^0.05 or less) protection against the membrane peroxidation. Results from experiments in which each 0-blocker (200 (JM) was added with no preincubation period showed inconsistent (propranolol or pindolol) or no (metoprolol, atenolol, or sotalol) protection against sarcolemmal peroxidation. Additional control experiments, in which various agents were added at the end of the incubation, did not show interference with the TBA assay. Separate experiments were also performed indicating that the rates of DHF auto-oxidation or superoxide radical generation, measured by the method of Goscin and Fridovich, 12 were not affected by any of the /3-blocking agents.
Time course studies showed that 200 /AM of propranolol, pindolol, or metoprolol provided pro-tective effects throughout 45 minutes of incubation; however, the same levels of atenolol or sotalol only produced significant effects at 20 minutes but not at 45 minutes of incubation (Figure 1 ).
In the next series of experiments, the ability of the five ^-blocking agents to inhibit lipid peroxidation in sarcolemma was compared under conditions described in Table 1 . As shown in Figure 2 , all five /3-blockers were able to inhibit peroxide formation in a concentration-dependent manner; their relative inhibitory potency was propranolol>pindolol> metoprolol>atenolol>sotalol. Propranolol is a highly potent and effective agent that produced complete inhibition (>95%) at high concentrations and achieved a significant effect at 20 /xM (24.7% inhibition, p<0.01). In data not shown, complete inhibition could not be achieved with the other four /J-blockers at concentrations higher than 800 /AM. Based on the data in Figure 2 , the concentrations of propranolol, pindolol, and metoprolol required to inhibit MDA formation by 50% were calculated and compared with their relative hydrophobicities, which are expressed as log octanol/water partition coefficients (Table 2) . Propranolol, the most effective agent, is most hydrophobic, whereas atenolol and sotalol are less hydrophobic and less effective.
Since the pH of ischemic cardiac tissue may fall to as low as 5.8-6.0, 13 the effect of acidotic pH on /3-blocker-inhibited lipid peroxidation was studied ( Figure 3 Figure 1 .
tAdapted from Cruickshank.
14 slightly whereas those of metoprolol, atenolol, and sotalol decreased to a larger extent (30-50%) at high concentrations ( Figure 3 ). Discussion As an index of membrane lipid peroxidative injury, MDA formation assayed by the TBA method was used in our study because of its sensitivity and simplicity. Despite some controversy about the specificity of the TBA-MDA methodology, the assay remains a useful tool in monitoring relative lipid peroxidation events in vitro. 1015 With an isolated membrane system, many of the intracellular components and metabolic systems that may affect the level of MDA formation or interfere with the TBA-MDA assay 1015 are absent; therefore, the TBA assay can still be used as a reasonable indicator of the relative extent of the membrane lipid peroxidation. In this study, since nonspecific assay interference from the agents has been ruled out, the data are interpreted to indicate that /3-blockers possess significant antiperoxidative potency against sarcolemmal lipid peroxidation. In addition, their order of potency, with the exception of metoprolol, appears to follow the degree of lipophilicity; propranolol, being most lipophilic, is the most potent agent. Since a preincubation period is required, we suggest that the observed effect does not result from direct scavenging of free radicals generated in the aqueous phase but rather from an interaction of the /3-blockers with the sarcolemmal membrane lipids. In addition to their receptor blocking activity, /3-blockers such as propranolol and pindolol possess membrane stabilizing/local anesthetic properties. 16 Since the concentrations required for the /J-blockers to produce significant effects were well above the range needed to block /3-adrenergic receptors, it is reasonable to speculate that all of the effects observed were contributed by nonspecific membrane effects such as membrane stabilizing activity. However, both quinidine and lidocaine are well-known local anesthetics and are relatively lipophilic with their log octanol/water partition coefficient (log P) vaJues (1.56 and 1.81, respectively), comparable to that of pindolol (1.75); yet neither quinidine nor lidocaine provides major inhibition of sarcolemmal peroxidation, whereas pindolol and other /3-blockers do ( Table 1) .
As common structural features, all /3-blockers consist of an aromatic moiety linked to the ethanolamine side chain by an oxymethylene bridge (except sotalol). 16 Presumably, much of the lipophilicity of each agent is contributed by the aromatic ring structure. Propranolol is more lipophilic because of its naphthalene moiety (or a two-ring structure).
Interactions of propranolol with model membranes and protein-depleted sarcoplasmic reticulum lipids, as studied by neutron diffraction techniques, indicate that the naphthalene moiety of propranolol is localized within the hydrocarbon center of the membrane bilayer. 17 In additional experiments, sarcolemmal membranes were pretreated with the highly lipophilic (log P>3.50) naphthalene (up to 400 fiM) before exposure to free radicals; interestingly, no protection (<10%) was observed. This result suggests that solvation of the lipophilic aromatic structure alone into the membranes does not provide protection. However, a structurally related compound, 1-methoxynaphthalene at 200 ^.M, was found to have protective activity approaching 50-60% of that of propranolol at the same concentration. This observation suggests that the naphthyoxy structure may possess "true" antioxidant activity similar to that of conventional chainbreaking antioxidants. 18 Antioxidants of this class are usually phenols or aromatic amines, and they owe their antioxidant activity to their ability to trap peroxy radicals inside the membrane. 18 From a structural point of view, all /3-blockers do have the aromatic resonance rings to stabilize trapped radicals as most classic antioxidants have in common. However, such a property for all the /3-blockers remains to be determined by more direct experiments measuring the rate constant of the agents with peroxy radicals. 18 Alternatively, since /J-blockers are cationic amphiphiles, and since a variety of cationic amphiphiles have been demonstrated to form complexes with phospholipids, 1920 interactions of the /3-blockers with the sarcolemmal membrane might result in drug-phospholipid complexes, which are less susceptible to free radical attack. The efficacy of each agent may then depend on the degree of drug-lipid complexing, which in turn depends on the lipophilicity of each agent. The present results neither support nor exclude this possibility.
To our knowledge this study represents the first report describing protective effects of these cardiovascular drugs against lipid peroxidation in cardiac membranes, though anti-cancer agents such as anthracenediones (which are compounds with polyaromatic rings) were reported to have inhibitory effects on cardiac lipid peroxidation. 21 Although elucidation of the exact mechanisms by which /3-blockers, especially propranolol, protect against sarcolemmal lipid peroxidation requires further study, the observed phenomenon may be of potential therapeutic significance. During cardiac ischemia, the level of free radicals, measured by electron spin resonance techniques, has been reported to increase fourfold in the coronary venous effluent of canine heart within 5 minutes after coronary artery occlusion. 2 Electron spin resonance studies of free radical production in ischemic/reperfused rat hearts in our laboratory clearly indicate that maximal oxygen free radical production is seen in the effluent 3 minutes after the introduction of reperfusion. 22 Both studies suggest that excessive free radicals are present in the extracellular compartment and may be able to attack the sarcolemmal membranes of the cardiocytes. Since long term administration of amphiphilic drugs such as propranolol may produce a significant accumulation in myocardial tissue, 23 it is reasonable to speculate that the /3-blockers, in the lipid phase of the sarcolemmal membrane, may provide a protective effect in vivo when free radicals are present.
